What is the difference between spirometry, pulse oximetry (SpO2), and forced expiratory volume in one second (FEV1)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Understanding the Differences Between Spirometry, SpO2, and FEV1

These are three distinct but complementary respiratory measurements: spirometry is the overall test procedure that measures airflow and lung volumes over time; FEV1 is a specific measurement obtained from spirometry representing the volume of air forcefully exhaled in the first second; and SpO2 (pulse oximetry) is a completely separate test that measures oxygen saturation in the blood, not lung volumes or airflow.

What Each Test Measures

Spirometry

Spirometry is a physiological test that measures how an individual inhales or exhales volumes of air as a function of time 1. It's the umbrella term for the entire testing procedure. Think of it as the "test" itself, not a single measurement. The primary signals measured can be either volume or flow 1.

Key spirometric measurements include:

  • Forced Vital Capacity (FVC): The total volume delivered during a forceful, complete expiration starting from full inspiration
  • FEV1: The volume delivered in the first second of the FVC maneuver
  • FEV1/FVC ratio: Used to identify airflow obstruction 1

FEV1 (Forced Expiratory Volume in One Second)

FEV1 is one specific measurement derived from the spirometry test - it represents the volume of air forcefully exhaled in the first second of the FVC maneuver 1. This is not a separate test but rather a key data point obtained during spirometry. FEV1 is crucial for:

  • Diagnosing obstructive lung diseases (asthma, COPD)
  • Assessing disease severity
  • Monitoring disease progression over time

The FEV1/VC ratio below the 5th percentile of predicted is the most important parameter for identifying obstructive impairment 2.

SpO2 (Pulse Oximetry)

SpO2 is an entirely different measurement that assesses arterial oxygen saturation using a non-invasive finger or ear clip device - it tells you nothing about lung volumes or airflow mechanics. While spirometry measures mechanical lung function, pulse oximetry measures gas exchange effectiveness.

Critical Clinical Distinctions

They Measure Different Aspects of Respiratory Function

  • Spirometry/FEV1: Measures airflow obstruction and lung volumes - answers "Can the patient move air in and out effectively?"
  • SpO2: Measures oxygenation status - answers "Is adequate oxygen reaching the bloodstream?"

Poor Correlation Between Measurements

Importantly, SpO2 and FEV1 are largely independent of each other 3. Research shows no statistically significant correlation between FEV1% predicted and SpO2 values in COPD patients 3. You can have:

  • Severe airflow obstruction (low FEV1) with normal oxygen saturation
  • Normal spirometry with low oxygen saturation (in conditions affecting gas exchange like interstitial lung disease)

However, there is a moderate correlation between FEV1/FVC ratio and SpO2 (r=0.556) 3, and SpO2 correlates better with PaO2 (r=0.80) and PaCO2 (r=-0.74) 4.

Clinical Applications

When to Use Spirometry/FEV1

Spirometry is indicated for 1:

  • Evaluating symptoms like dyspnea or chronic cough
  • Diagnosing obstructive (asthma, COPD) or restrictive lung diseases
  • Assessing pre-operative risk
  • Monitoring disease progression
  • Evaluating response to therapy

When to Use Pulse Oximetry

Pulse oximetry is valuable for 5:

  • Acute dyspnea or worsening respiratory symptoms
  • Suspected respiratory insufficiency/failure
  • Monitoring patients with known severe COPD (especially during exacerbations)
  • Exercise-related dyspnea assessment

In COPD exacerbations, 22% of patients show SpO2 ≤92%, and a cutoff of ≤88.5% has 95.6% sensitivity and 80.6% specificity for detecting hypoxemia 4.

Common Pitfalls to Avoid

Do not use pulse oximetry as a screening tool to decide who needs spirometry - it has poor diagnostic value for this purpose (sensitivity 79%, specificity only 37% for detecting COPD when SpO2 <98%) 6. Pulse oximetry cannot substitute for spirometry in diagnosing airflow obstruction.

Do not assume normal SpO2 means normal lung function - oxygen saturation can remain normal until disease is quite advanced, particularly in obstructive diseases where compensatory mechanisms maintain oxygenation despite significant airflow limitation 3.

Do not confuse FEV1 with FVC - FEV1 is the volume in the first second, while FVC is the total volume exhaled during the entire forced maneuver. The ratio between them (FEV1/FVC) is what identifies obstruction 2.

References

Guideline

standardisation of spirometry.

European Respiratory Journal, 2005

Guideline

interpretative strategies for lung function tests.

European Respiratory Journal, 2005

Research

Can spirometry, pulse oximetry and dyspnea scoring reflect respiratory failure in patients with chronic obstructive pulmonary disease exacerbation?

Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2007

Research

Can pulse oximetry select patients for screening spirometry?

Primary care respiratory journal : journal of the General Practice Airways Group, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.